SCHEMBL15966769

SCHEMBL15966769

CCn1c(=O)oc(=O)c2c(Br)cccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.38
USP2 O75604 2/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.37
GRM2 Q14416 1/20 0.36
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
CYP1A2 P05177 2/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
NPSR1 Q6W5P4 2/20 0.34
CYP1B1 Q16678 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
CNR2 P34972 1/20 0.33
MIF P14174 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALPI P09923 1/20 0.33
MAPT P10636 1/20 0.33
JAK2 O60674 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30198157 0.84 GRM2 (0.40) ALDH1A1USP2HPGDTSHRMAPK1
SCHEMBL24054967 0.84 GRM2 (0.40) ALDH1A1USP2HPGDTSHRMAPK1
SCHEMBL24074349 0.83 ELANE (0.41) ALDH1A1USP2HPGDTSHRMAPK1
SCHEMBL6732982 0.81 ALDH1A1 (0.40) ALDH1A1TSHRMAPK1GRM2NPSR1
SCHEMBL15966707 0.81 ALDH1A1 (0.42) ALDH1A1USP2HPGDTSHRMAPK1
SCHEMBL28357403 0.79 ELANE (0.44) USP2HPGDTSHRMAPK1MEN1
SCHEMBL15966770 0.79 JAK2 (0.46) ALDH1A1USP2HPGDGRM2MEN1
SCHEMBL24073980 0.78 MEN1 (0.48) ALDH1A1HPGDTSHRMEN1KMT2A
SCHEMBL30339031 0.78 MEN1 (0.48) ALDH1A1HPGDTSHRMEN1KMT2A
SCHEMBL6305077 0.73 ALDH1A1 (0.59) ALDH1A1USP2HPGDTSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9757369-B2 Heterocyclic GSK-3 allosteric modulators CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) (ES) 2017-09-12 US disclosed
US-20170196850-A1 Heterocyclic GSK-3 Allosteric Modulators CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) (ES) 2017-07-13 US disclosed
EP-2769720-B1 HETEROCYCLIC GSK-3 ALLOSTERIC MODULATORS CONSEJO SUPERIOR DE INVESTIG CIENTÍFICAS (CSIC) (ES) 2017-03-29 EP disclosed
US-9585879-B2 Heterocyclic GSK-3 allosteric modulators CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) (ES) 2017-03-07 US disclosed
US-20160113918-A1 Heterocyclic GSK-3 Allosteric Modulators CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) (ES) 2016-04-28 US disclosed
US-9193688-B2 Heterocyclic GSK-3 allosteric modulators CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) 2015-11-24 US disclosed
US-20150057311-A1 Heterocyclic GSK-3 Allosteric Modulators CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) (ES) 2015-02-26 US disclosed
EP-2769720-A1 HETEROCYCLIC GSK-3 ALLOSTERIC MODULATORS Consejo Superior De Investigaciones Científicas (CSIC) (ES) 2014-08-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170196850-A1 Heterocyclic GSK-3 Allosteric Modulators GSK3B, GSK3A, GSKIP ALDH1A1 3820/4885USP2 2756/4885HPGD 2265/4885
US-20160113918-A1 Heterocyclic GSK-3 Allosteric Modulators GSK3B, GSK3A, GSKIP ALDH1A1 3820/4885USP2 2756/4885HPGD 2265/4885
US-20150057311-A1 Heterocyclic GSK-3 Allosteric Modulators GSK3B, GSK3A, GSKIP ALDH1A1 3820/4885USP2 2756/4885HPGD 2265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.